Legal experts discuss a potential strategy by the Trump administration to use Tylenol litigation as a "workaround" to challenge vaccine manufacturer immunity. Because Tylenol does not have the same statutory immunity as vaccines, lawsuits in federal court could force discovery regarding how acetaminophen interacts with vaccinations. This could publicly expose data on vaccine safety and potentially lead to the rescinding of the 1986 Vaccine Injury Act's protections.






